We are live on ! Find out more
SMA

Seven Mile Advisory Portfolio holdings

AUM $139M
1-Year Est. Return 26.01%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+26.01%
3 Year Est. Return
+102.71%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$20.1M
Cap. Flow
+$8.01M
Cap. Flow %
6.94%
Top 10 Hldgs %
45.5%
Holding
156
New
28
Increased
77
Reduced
26
Closed
6

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$248K
2
GILD icon
Gilead Sciences
GILD
+$220K
3
BTI icon
British American Tobacco
BTI
+$206K
4
SNY icon
Sanofi
SNY
+$206K
5
UL icon
Unilever
UL
+$204K

Sector Composition

Rank Sector Weight
1 Technology 22.42%
2 Communication Services 9.31%
3 Financials 7.66%
4 Healthcare 6.24%
5 Consumer Discretionary 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNDF icon
101
Schwab Fundamental International Large Company Index ETF
FNDF
$24.9B
$270K 0.23%
8,000
BBEU icon
102
JPMorgan BetaBuilders Europe ETF
BBEU
$9.35B
$263K 0.23%
4,640
+348
+8% +$18.3K
ARCC icon
103
Ares Capital
ARCC
$13.5B
$260K 0.23%
13,000
BBCA icon
104
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
$260K 0.23%
4,051
NOW icon
105
ServiceNow
NOW
$115B
$259K 0.22%
1,830
-5
-0.3% -$630
TGT icon
106
Target
TGT
$65.6B
$254K 0.22%
+1,781
New +$217K
ELV icon
107
Elevance Health
ELV
$81.5B
$249K 0.22%
+528
New +$244K
CI icon
108
Cigna
CI
$73.7B
$248K 0.22%
828
-71
-8% -$20.7K
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$121B
$246K 0.21%
604
-1
-0.2% -$369
TMO icon
110
Thermo Fisher Scientific
TMO
$213B
$246K 0.21%
+463
New +$224K
BMY icon
111
Bristol-Myers Squibb
BMY
$133B
$245K 0.21%
4,777
+1,047
+28% +$55K
NFRA icon
112
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3B
$245K 0.21%
4,579
STLA icon
113
Stellantis
STLA
$21.7B
$239K 0.21%
+10,255
New +$212K
GS icon
114
Goldman Sachs
GS
$300B
$238K 0.21%
617
-5
-0.8% -$1.67K
TM icon
115
Toyota
TM
$224B
$234K 0.2%
1,275
+64
+5% +$11.7K
GSK icon
116
GSK
GSK
$104B
$230K 0.2%
6,207
+30
+0.5% +$1.08K
RSPT icon
117
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
$228K 0.2%
+7,000
New +$206K
GQRE icon
118
FlexShares Global Quality Real Estate Index Fund
GQRE
$426M
$226K 0.2%
+4,043
New +$205K
MFC icon
119
Manulife Financial
MFC
$73.9B
$225K 0.2%
+10,198
New +$196K
ZTS icon
120
Zoetis
ZTS
$32.4B
$223K 0.19%
+1,131
New +$200K
ICE icon
121
Intercontinental Exchange
ICE
$85.6B
$219K 0.19%
+1,708
New +$194K
UBS icon
122
UBS Group
UBS
$173B
$219K 0.19%
+7,072
New +$186K
EPD icon
123
Enterprise Products Partners
EPD
$82.3B
$216K 0.19%
8,183
VTEB icon
124
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$215K 0.19%
+4,213
New +$207K
TSM icon
125
TSMC
TSM
$2.1T
$214K 0.19%
+2,054
New +$196K

Similar funds

Seven Mile Advisory's Q4 2023 Portfolio in Review

As of Q4 2023, Seven Mile Advisory held 156 positions worth $115M, up 21% from $95.2M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Seven Mile Advisory deployed $8.01M of net new capital in Q4 2023, opening 28 new positions and adding to 77 existing holdings. Its largest new stake was NextEra Energy: 4,538 shares worth $276K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $89.3K trimmed.

  • Seven Mile Advisory's largest Q4 2023 buy was NextEra Energy: 4,538 shares worth $276K.
  • Seven Mile Advisory added most to iShares Russell 1000 Growth ETF in Q4 2023, an estimated $574K increase.
  • Seven Mile Advisory's biggest Q4 2023 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $89.3K.
  • Seven Mile Advisory fully exited AstraZeneca in Q4 2023, selling an estimated $248K.
  • Seven Mile Advisory's ten largest holdings make up 46% of its $115M portfolio in Q4 2023.
  • Seven Mile Advisory opened 28 new positions and closed 6 in Q4 2023.
  • Seven Mile Advisory's portfolio value rose 21% quarter-over-quarter to $115M.

Based on Seven Mile Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.